-+ 0.00%
-+ 0.00%
-+ 0.00%

Teva Submits NDA to FDA for Medincell's Olanzapine Extended-Release Injectable Suspension for Schizophrenia

路透·12/09/2025 13:50:15

登录查看新闻详情